Bank Of America Corp Keros Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 171,071 shares of KROS stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171,071

Previous 178,994 4.43%

Holding current value

$2.68 Million

Previous $8.18 Million 21.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.68 - $58.07 $330,230 - $460,088	-7,923 Reduced 4.43%	171,071 $9.93 Million
Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $290,527 - $435,922	6,517 Added 3.78%	178,994 $8.18 Million
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $865,304 - $1.48 Million	-20,972 Reduced 10.84%	172,477 $11.4 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $3.72 Million - $5.63 Million	137,236 Added 244.14%	193,449 $7.69 Million
Q2 2023 Aug 14, 2023	SELL	$37.26 - $51.01 $724,930 - $992,450	-19,456 Reduced 25.71%	56,213 $2.26 Million
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $403,128 - $577,064	9,728 Added 14.75%	75,669 $3.23 Million
Q4 2022 Feb 10, 2023	BUY	$39.45 - $51.77 $506,182 - $664,260	12,831 Added 24.16%	65,941 $3.17 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $398,679 - $575,360	14,341 Added 36.99%	53,110 $2 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $116,614 - $300,339	4,480 Added 13.07%	38,769 $1.07 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $123,243 - $173,687	2,926 Added 9.33%	34,289 $1.86 Million
Q4 2021 Feb 08, 2022	BUY	$36.95 - $62.89 $44,931 - $76,474	1,216 Added 4.03%	31,363 $1.84 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $648,447 - $968,351	22,154 Added 277.17%	30,147 $1.19 Million
Q2 2021 Sep 13, 2021	BUY	$42.4 - $70.11 $338,903 - $560,389	7,993 New	7,993 $339,000

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $403M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Keros Therapeutics, Inc. Transaction History